1.
Oehler VG, Berman E, Huang IJ. Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing. Haematologica 2026; 111(7):2266-2280; https://doi.org/10.3324/haematol.2025.288334.